ADTRAN (ADTN) Q3 2026 Earnings Call Transcript

ADTRAN reported Q3 revenue of $281.2 million, up approximately 1% year over year, while management said supply constraints prevented shipment of tens of millions of dollars in orders. Non-GAAP operating margin was 5%, and non-GAAP EPS was $0.09; Q4 guidance is $272 million–$292 million in revenue and a 1%–5% operating margin. Hyperscaler revenue grew more than 200% year over year, but negative free cash flow was $39.4 million and management expects component supply to remain a key headwind next year.

Analysis

The key issue is conversion, not demand: ADTN has orders it cannot ship, while scarce optics, lasers and other components raise costs. That creates a two-sided risk—revenue deferred rather than lost if supply clears, but competitors with available capacity can take share or become qualified alternatives. Customer relationships may slow substitution, but extended delays can weaken that protection.

Near term, treat reported gross margin as flattered: the tariff refund is nonrecurring, and management attributes most underlying pressure to supply costs. Price increases reaching the remaining customers by early 2027 and product redesigns could help, but neither offsets costs until realized in margins. Negative free cash flow, rising inventory and cash collections that have yet to normalize make execution and liquidity conversion more important than the growth narrative; continued share purchases of the subsidiary add to that capital-allocation tension.

Over 1–3 months, the Q4 margin range and evidence of collections are the tests. Over 6–18 months, optical demand, BEAD and new cloud products offer upside, but LiteWave’s meaningful contribution is back-end loaded and European vendor-replacement timing is politically uncertain. Do not capitalize the replacement TAM or early product interest as booked revenue. The contrarian risk is that strong hyperscaler growth and constrained shipments invite a bullish read-through, while supply-cost inflation and cash conversion—not demand—may govern earnings. Conversely, if supply eases, deferred orders could produce a faster rebound than reported growth implies.

Key Decisions for Investors

• Keep ADTN at neutral/underweight rather than buying the demand narrative ahead of proof. Reassess after Q4 results for improved operating cash flow and inventory/receivables normalization; failure to convert collections as guided would strengthen the cautious view.
• Use supply availability and normalized gross margin as the primary 1–3 month monitors. A sustained improvement in shipments alongside margin recovery excluding tariff benefits would falsify the near-term caution; continued component inflation or further shipment constraints would reinforce it.
• Treat European replacement legislation and LiteWave/MicroMux Quattro as watch items, not near-term earnings catalysts. Track enacted EU timelines, customer qualification and production orders before assigning material value.
• Watch the capital-allocation trade-off: further subsidiary share purchases while free cash flow remains negative would increase concern if working capital fails to normalize. Confirm cash-flow improvement in filings rather than relying solely on management’s expectation.